Article Details

Eli Lilly & Co's Promising Growth Driven by Mounjaro and Zepbound Performance

Retrieved on: 2024-12-08 18:02:17

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly & Co's Promising Growth Driven by Mounjaro and Zepbound Performance. View article details on hiswai:

Excerpt

In a report released on December 6, Terence Flynn from Morgan Stanley maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), wit...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo